ID: ALA5187572

Max Phase: Preclinical

Molecular Formula: C42H72N4O12

Molecular Weight: 825.05

Associated Items:

Representations

Canonical SMILES:  CCCCC[C@@H]1OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)NC(=O)[C@H](CCCCC)OC(=O)[C@@H](C)NC1=O

Standard InChI:  InChI=1S/C42H72N4O12/c1-11-15-19-23-31-35(47)44-28(6)40(52)57-33(25-21-17-13-3)37(49)46(10)30(8)42(54)58-34(26-22-18-14-4)38(50)45(9)29(7)41(53)56-32(24-20-16-12-2)36(48)43-27(5)39(51)55-31/h27-34H,11-26H2,1-10H3,(H,43,48)(H,44,47)/t27-,28-,29-,30-,31+,32+,33+,34+/m1/s1

Standard InChI Key:  BWCWGRFPRUKNCP-NYQMAADGSA-N

Associated Targets(non-human)

Ryanodine receptor 2 21 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 825.05Molecular Weight (Monoisotopic): 824.5147AlogP: 4.67#Rotatable Bonds: 16
Polar Surface Area: 204.02Molecular Species: NEUTRALHBA: 12HBD: 2
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.76CX Basic pKa: CX LogP: 6.50CX LogD: 6.50
Aromatic Rings: 0Heavy Atoms: 58QED Weighted: 0.12Np Likeness Score: 0.67

References

1. Smith AN, Thorpe MP, Blackwell DJ, Batiste SM, Hopkins CR, Schley ND, Knollmann BC, Johnston JN..  (2022)  Structure-Activity Relationships for the N-Me- Versus N-H-Amide Modification to Macrocyclic ent-Verticilide Antiarrhythmics.,  13  (11.0): [PMID:36385927] [10.1021/acsmedchemlett.2c00377]

Source